White Paper
SEA and Pakistan: Emerging Hub for Vaccine Clinical Trials
A strategic perspective for clinical development in Southeast Asia and Pakistan
Nov 10, 2025
Southeast Asia (SEA) and Pakistan are quickly establishing themselves as a competitive region for global vaccine clinical trials. Their strengths lie in their diverse patient populations, responsive regulatory systems, and alignment with global health priorities. The region offers access to genetically diverse, treatment-naïve populations in both urban and rural settings, enabling efficient recruitment and relevant data generation. Combined with streamlined approvals and an increasingly mature clinical trial ecosystem, South East Asia is becoming an essential geography for pharmaceutical and biotech companies pursuing vaccine development.